A Multicenter, Double-blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-Release Adjunctive Therapy in Patients With Primary Generalized Tonic-Clonic Seizures
Phase of Trial: Phase III
Latest Information Update: 06 Jan 2017
At a glance
- Drugs Lamotrigine (Primary)
- Indications Tonic-clonic epilepsy
- Focus Registrational; Therapeutic Use
- Sponsors GlaxoSmithKline
- 20 May 2009 Actual end date (1 Jul 2008) added as reported by ClinicalTrials.gov.
- 20 May 2009 Additional location Malaysia identified as reported by ClinicalTrials.gov.
- 06 Aug 2008 Primary endpoint 'Seizure-frequency' has been met.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History